HLA-G and ovarian carcinoma: Interestingly, following 5-aza-dC treatment of ovarian cancer cells (BG-1) HLA-G −242 site was shown to remain methylated, while hypomethylation of sequences was observed within 5′ HLA-G regulatory region [85].